Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2025)

Krystal Biotech (KRYS) has disclosed Other Operating Expenses for 3 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Dec 2025, up 239.08% year-over-year, with the annual reading at $100.0 million for FY2023, N/A changed from the prior year.
  • Other Operating Expenses hit $6.6 million in Q4 2025 for Krystal Biotech, up from $4.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $100.0 million in Q3 2023 to a low of -$19.0 million in Q2 2024.
  • Historically, Other Operating Expenses has averaged $11.7 million across 3 years, with a median of $4.6 million in 2025.
  • Biggest five-year swings in Other Operating Expenses: plummeted 51.93% in 2024 and later soared 137.73% in 2025.
  • Year by year, Other Operating Expenses stood at $100.0 million in 2023, then plummeted by 118.99% to -$19.0 million in 2024, then surged by 134.71% to $6.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for KRYS at $6.6 million in Q4 2025, $4.3 million in Q3 2025, and $7.2 million in Q2 2025.